Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1984-07-16
1986-10-21
Hazel, Blondel
Chemistry: molecular biology and microbiology
Spore forming or isolating process
424 85, 530387, 4351722, C12N 500, A61K 39395, C07K 1500
Patent
active
046185852
ABSTRACT:
Continuous hybrid cell lines for producing monoclonal antibodies, the antibodies specific for an antigenic determinant unique to cervical cancer cells, have been developed. The hybrid cell lines were established by fusing differentiated lymphoid cells primed with intact human cervical cancer cells with myeloma cells, particularly plasmacytoma cells. The resulting fused hybrid cells were cultured in HAT tissue culture media which included a small concentration of deoxycytidine. Deoxycytidine was found to enhance the growth of the hybrid cells and subsequent yield of monoclonal antibodies secreted therefrom. Hybrid cell lines secreting monoclonal antibodies to antigenic determinants unique for human cervical cancer cells can be maintained indefinitely in culture to produce large amounts of homogenous anti-cervical cancer cell antibody.
REFERENCES:
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4271145 (1981-06-01), Wands et al.
Schlon et al., "Generation of Human Monoclonal Antibodies Reactive with Human Mammary Carcinoma Cells" Proc. Natl. Acad. Sci. USA 77:6841, (Nov. 1980).
Dippold et al., "Cell Surface Antigens of Human Malignant Melanoma: Definition of Six Antigenic Systems with Mouse Monoclonal Antibodies" Proc. Natl. Acad. Sc: USA 77:6114 (Oct. 1980).
Glass, David, "Medicine's Micro Missiles" Science Digest, pp. 30, 31, 114, (Jan. 1982).
Lakachura et al., "Monoclonal Antibodies Against Human Hela Cell Surface Antigens" Abstract of Tissue Culture Association (Mar. 20, 1981).
Wiels et al., "Monoclonal Antibody Against a Burkitt Lymphoma Associated Antigen", Proc. Natl. Acad. Sci. USA 78:6485, (Oct. 1981).
Board of Regents , The University of Texas System
Hazel Blondel
LandOfFree
Hybridoma cell lines producing monoclonal antibodies directed ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridoma cell lines producing monoclonal antibodies directed ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma cell lines producing monoclonal antibodies directed ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1289868